<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">antibiotics</journal-id><journal-title-group><journal-title xml:lang="ru">Антибиотики и Химиотерапия</journal-title><trans-title-group xml:lang="en"><trans-title>Antibiot Khimioter = Antibiotics and Chemotherapy</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">0235-2990</issn><publisher><publisher-name>ООО «Издательство ОКИ»</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">antibiotics-692</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL PAPERS</subject></subj-group></article-categories><title-group><article-title>Получение липосомальных форм модифицированных пиримидиновых нуклеозидов и изучение их антибактериальных свойств</article-title><trans-title-group xml:lang="en"><trans-title>Development of Liposomal Forms of Modified Pyrimidine Nucleosides and Investigation of Their Antibacterial Properties</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Карпенко</surname><given-names>И. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Karpenko</surname><given-names>I. L.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сорокоумова</surname><given-names>Г. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Sorokoumova</surname><given-names>G. M.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сумарукова</surname><given-names>И. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Sumarukova</surname><given-names>I. G.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гайдукевич</surname><given-names>С. К.</given-names></name><name name-style="western" xml:lang="en"><surname>Gaydukevich</surname><given-names>S. K.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Зарецкая</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Zaretskaya</surname><given-names>M. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ефременкова</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Efremenkova</surname><given-names>Q. V.</given-names></name></name-alternatives><email xlink:type="simple">ovefr@yandex.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Александрова</surname><given-names>Л. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Alexandrova</surname><given-names>L. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>Институт молекулярной биологии им. В. А. Энгельгардта РАН</institution><country>Russian Federation</country></aff><aff xml:lang="ru" id="aff-2"><institution>Московский технологический университет, Институт тонких химических технологий</institution><country>Russian Federation</country></aff><aff xml:lang="ru" id="aff-3"><institution>Научно-исследовательский институт по изысканию новых антибиотиков им. Г. Ф. Гаузе</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2016</year></pub-date><pub-date pub-type="epub"><day>13</day><month>05</month><year>2020</year></pub-date><volume>61</volume><issue>11-12</issue><fpage>9</fpage><lpage>15</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Карпенко И.Л., Сорокоумова Г.М., Сумарукова И.Г., Гайдукевич С.К., Зарецкая М.А., Ефременкова О.В., Александрова Л.А., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Карпенко И.Л., Сорокоумова Г.М., Сумарукова И.Г., Гайдукевич С.К., Зарецкая М.А., Ефременкова О.В., Александрова Л.А.</copyright-holder><copyright-holder xml:lang="en">Karpenko I.L., Sorokoumova G.M., Sumarukova I.G., Gaydukevich S.K., Zaretskaya M.A., Efremenkova Q.V., Alexandrova L.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.antibiotics-chemotherapy.ru/jour/article/view/692">https://www.antibiotics-chemotherapy.ru/jour/article/view/692</self-uri><abstract><p>Созданы комплексы различного состава фосфохолин-кардиолипин-производные 2'-дезоксиуридина, что позволило получить водорастворимую форму аналогов нуклеозидов с установленной ранее противотуберкулёзной активностью. Установлено, что полученные липосомы эффективно проникают в клетки, а возрастание цитотоксичности, свидетельствует об увеличении накопления нуклеозида в клетках. Этот результат подтверждает возможность применения липосомальных форм для доставки малорастворимых соединений в клетки для дальнейшего изучения их эффективности. Показано, что введение модифицированных нуклеозидов в липосомальной форме в бактериальные клетки не влияет на рост последних.</p></abstract><trans-abstract xml:lang="en"><p>Different phosphocholine-cardlolipin-2'-deoxyuridine inclusion complexes were developed, that allowed to compose a water-soluble form of nucleoside analogues with previously defined antituberculosis activity. It was found that the resulting liposomes effectively penetrated to the cells. The increase of cytotoxicity was undoubtedly indicative of accumulation of the nucleoside in the cell culture. The result proved the ability of the liposomes for delivery of the low-soluble compounds to the cells for further investigation of their efficacy. It was shown that treatment of the bacterial cells with the liposomes of the modified nucleosides did not affect the bacterial growth.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>липосомы</kwd><kwd>модифицированные пиримидиновые нуклеозиды</kwd><kwd>фосфолипиды</kwd><kwd>цитотоксичность</kwd></kwd-group><kwd-group xml:lang="en"><kwd>Mycobacterium tuberculosis</kwd><kwd>Mycobacterium smegmatis</kwd><kwd>liposomes</kwd><kwd>modified pyrimidine nucleosides</kwd><kwd>phospholipids</kwd><kwd>cytotoxicity</kwd><kwd>Mycobacterium tuberculosis</kwd><kwd>M.smegmatis</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Couvin D., Rastogi N. Tuberculosis - A global emergency: tools and methods to monitor, understand, and control the epidemic with specific example of the Beijing lineage. Tuberculosis (Edinb). 2015; 95: Suppl 1: S177-189.</mixed-citation><mixed-citation xml:lang="en">Couvin D., Rastogi N. Tuberculosis - A global emergency: tools and methods to monitor, understand, and control the epidemic with specific example of the Beijing lineage. Tuberculosis (Edinb). 2015; 95: Suppl 1: S177-189.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">TBDRUGS (Database of Drugs for Tuberculosis, version 1.0). Available from URL: http://bic.icmr.org.in/tbdrugs/tb_browse_name.php</mixed-citation><mixed-citation xml:lang="en">TBDRUGS (Database of Drugs for Tuberculosis, version 1.0). Available from URL: http://bic.icmr.org.in/tbdrugs/tb_browse_name.php</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Greco E. Santucci M.B., Sali M., De Angelis F.R., Papi M., De Spirito M., Delogu G., Colizzi V., Fraziano M. Natural lysophospholipids reduce Mycobacterium tuberculosis-induced cytotoxicity and induce anti-mycobacterial activity by a phagolysosome maturation-dependent mechanism in A549 type II alveolar epithelial cells. Immunology 2010; 129: 125-132.</mixed-citation><mixed-citation xml:lang="en">Greco E. Santucci M.B., Sali M., De Angelis F.R., Papi M., De Spirito M., Delogu G., Colizzi V., Fraziano M. Natural lysophospholipids reduce Mycobacterium tuberculosis-induced cytotoxicity and induce anti-mycobacterial activity by a phagolysosome maturation-dependent mechanism in A549 type II alveolar epithelial cells. Immunology 2010; 129: 125-132.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Greco E., Quintiliani G., Santucci M.B., Serafino A., Ciccaglione A.R., Marcantonio C., Papi M., Maulucci G., Delogu G., Martino A., Goletti D., Sarmati L., Andreoni M., Altieri A., Alma M., Caccamo N., Di Liberto D., De Spirito M., Savage N.D., Nisini R., Dieli F., Ottenhoff T.H., Fraziano M. Janus-faced liposomes enhance antimicrobial innate immune response in Mycobacterium tuberculosis infection PNAS 2012; 109: 21: E1360-1368.</mixed-citation><mixed-citation xml:lang="en">Greco E., Quintiliani G., Santucci M.B., Serafino A., Ciccaglione A.R., Marcantonio C., Papi M., Maulucci G., Delogu G., Martino A., Goletti D., Sarmati L., Andreoni M., Altieri A., Alma M., Caccamo N., Di Liberto D., De Spirito M., Savage N.D., Nisini R., Dieli F., Ottenhoff T.H., Fraziano M. Janus-faced liposomes enhance antimicrobial innate immune response in Mycobacterium tuberculosis infection PNAS 2012; 109: 21: E1360-1368.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Delogu G., Sali M., Rocca S., Quintiliani G., Santucci M.B., Greco E., Cabibbo A, Mariani F., Colizzi V., Fadda G., Fraziano M. Lysophosphatidic acid enhances antimycobacterial response during in vivo primary Mycobacterium tuberculosis infection. Cell Immunol 2011; 271: 1-4.</mixed-citation><mixed-citation xml:lang="en">Delogu G., Sali M., Rocca S., Quintiliani G., Santucci M.B., Greco E., Cabibbo A, Mariani F., Colizzi V., Fadda G., Fraziano M. Lysophosphatidic acid enhances antimycobacterial response during in vivo primary Mycobacterium tuberculosis infection. Cell Immunol 2011; 271: 1-4.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Misra A., Hickey A.J., Rossi C., Borchard G., Terada H., Makino K., Fourie P.B., Colombo P. Inhaled drug therapy for treatment of tuberculosis.Tuberculosis (Edinb). 2011; 91: 1: 71-81.</mixed-citation><mixed-citation xml:lang="en">Misra A., Hickey A.J., Rossi C., Borchard G., Terada H., Makino K., Fourie P.B., Colombo P. Inhaled drug therapy for treatment of tuberculosis.Tuberculosis (Edinb). 2011; 91: 1: 71-81.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Pandey R., Khuller G.K. Antitubercular inhaled therapy: opportunities, progress and challenges. J Antimicrob Chemother. 2005; 55: 4: 430-435.</mixed-citation><mixed-citation xml:lang="en">Pandey R., Khuller G.K. Antitubercular inhaled therapy: opportunities, progress and challenges. J Antimicrob Chemother. 2005; 55: 4: 430-435.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Khuller G.K., Kapur M., Sharma S.Liposome technology for drug delivery against mycobacterial infections. Curr Pharm Des 2004; 10: 26: 3263- 3274.</mixed-citation><mixed-citation xml:lang="en">Khuller G.K., Kapur M., Sharma S.Liposome technology for drug delivery against mycobacterial infections. Curr Pharm Des 2004; 10: 26: 3263- 3274.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Pandey R., Sharma S., Khuller G.K. Oral solid lipid nanoparticle-based antitubercular chemotherapy. Tuberculosis (Edinb) 2005; 85: 5-6: 415- 420.</mixed-citation><mixed-citation xml:lang="en">Pandey R., Sharma S., Khuller G.K. Oral solid lipid nanoparticle-based antitubercular chemotherapy. Tuberculosis (Edinb) 2005; 85: 5-6: 415- 420.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Vyas S.P., Kannan M.E., Jain S., Mishra V., Singh P. Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophages. Int J Pharm 2004; 269: 1: 37-49.</mixed-citation><mixed-citation xml:lang="en">Vyas S.P., Kannan M.E., Jain S., Mishra V., Singh P. Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophages. Int J Pharm 2004; 269: 1: 37-49.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Курунов Ю.Н., Каледин Б.И., Попова H.A., Пантелеева А.Г.Эффективность липосомальной формы рифампицина при лечении экспериментального туберкулёза мышей. Проблемы туберкулёза. 1992; 1-2: 13-15. / Kurunov Ju.N., Kaledin V.I., Popova N.A., Panteleeva A.G. Jeffektivnost' liposomal'noj formy rifampicina pri lechenii jeksperimental'nogo tuberkuljoza myshej. Problemy tuberkuljoza. 1992; 1-2: 13-15. [in Russian]</mixed-citation><mixed-citation xml:lang="en">Курунов Ю.Н., Каледин Б.И., Попова H.A., Пантелеева А.Г.Эффективность липосомальной формы рифампицина при лечении экспериментального туберкулёза мышей. Проблемы туберкулёза. 1992; 1-2: 13-15. / Kurunov Ju.N., Kaledin V.I., Popova N.A., Panteleeva A.G. Jeffektivnost' liposomal'noj formy rifampicina pri lechenii jeksperimental'nogo tuberkuljoza myshej. Problemy tuberkuljoza. 1992; 1-2: 13-15. [in Russian]</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Гуревич Г.Л., Березовская Л.Н., Мануйлов К.К. Особенности фармакокинетики рифампицина, включенного в липосомы, у крыс при внутритрахеальном введении Антибиотики и химиотер 1992; 37; 7: 25-28. / Gurevich G.L., Berezovskaja L.N., Manujlov K.K. Osobennosti farmakokinetiki rifampicina, vkljuchennogo v liposomy, u krys pri vnutritraheal'nom vvedenii Antibiotiki i khimioter 1992; 37; 7: 25-28.</mixed-citation><mixed-citation xml:lang="en">Гуревич Г.Л., Березовская Л.Н., Мануйлов К.К. Особенности фармакокинетики рифампицина, включенного в липосомы, у крыс при внутритрахеальном введении Антибиотики и химиотер 1992; 37; 7: 25-28. / Gurevich G.L., Berezovskaja L.N., Manujlov K.K. Osobennosti farmakokinetiki rifampicina, vkljuchennogo v liposomy, u krys pri vnutritraheal'nom vvedenii Antibiotiki i khimioter 1992; 37; 7: 25-28.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Labana S., Pandey R., Sharma S., Khuller G.K. Chemotherapeutic activity against murine tuberculosis of once weekly administered drugs (isoniazid and rifampicin) encapsulated in liposomes. Int J Antimicrob Agents 2002; 20: 4: 301-304.</mixed-citation><mixed-citation xml:lang="en">Labana S., Pandey R., Sharma S., Khuller G.K. Chemotherapeutic activity against murine tuberculosis of once weekly administered drugs (isoniazid and rifampicin) encapsulated in liposomes. Int J Antimicrob Agents 2002; 20: 4: 301-304.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Gaspar M. M., Neves S., Portaels F., Pedrosa J., Silva M. T., Cruz M. E. Therapeutic efficacy of liposomal rifabutin in a Mycobacterium avium model of infection.Antimicrob Agents Chemother 2000; 44: 9: 2424-2430.</mixed-citation><mixed-citation xml:lang="en">Gaspar M. M., Neves S., Portaels F., Pedrosa J., Silva M. T., Cruz M. E. Therapeutic efficacy of liposomal rifabutin in a Mycobacterium avium model of infection.Antimicrob Agents Chemother 2000; 44: 9: 2424-2430.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">De Clercq E.Human viral diseases: what is next for antiviral drug discovery? Curr Opin Virol 2012; 2: 572-579.</mixed-citation><mixed-citation xml:lang="en">De Clercq E.Human viral diseases: what is next for antiviral drug discovery? Curr Opin Virol 2012; 2: 572-579.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Шмаленюк Э. P., Кочетков С. H., Александрова Л. А. Новые ингибиторы роста M.tuberculosis на основе модифицированных пиримидиновых нуклеозидов и их аналогов. Успехи химии 2013; 82: 896-915. / Shmalenjuk Je. R., Kochetkov S. N., Aleksandrova L. A. Novye ingibitory rosta M.tuberculosis na osnove modificirovannyh pirimidinovyh nukleozidov i ih analogov. Uspehi himii 2013; 82: 896-915. [in Russian]</mixed-citation><mixed-citation xml:lang="en">Шмаленюк Э. P., Кочетков С. H., Александрова Л. А. Новые ингибиторы роста M.tuberculosis на основе модифицированных пиримидиновых нуклеозидов и их аналогов. Успехи химии 2013; 82: 896-915. / Shmalenjuk Je. R., Kochetkov S. N., Aleksandrova L. A. Novye ingibitory rosta M.tuberculosis na osnove modificirovannyh pirimidinovyh nukleozidov i ih analogov. Uspehi himii 2013; 82: 896-915. [in Russian]</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Андреевская C.H., Смирнова Т.Г., Жогина Ю.А., Смирнова И., Микулович Ю.Л., Сорокоумова Г.М., Черноусова Л.Н., Селищева А.А., Швец В.И. Влияние экзогенного кардиолипина на рост и жизнеспособность Mycobacterium tuberculosis H37Rv in vitro. Доклады Академии наук 2010; 434: 5: 705-708. / Andreevskaja S.N., Smirnova T.G., Zhogina Ju.A., Smirnova T.G., Mikulovich Ju.L., Sorokoumova G.M., Chernousova L.N., Selishheva A.A., Shvec V.I. Vlijanie jekzogennogo kardiolipina na rost i zhiznesposobnost' Mycobacterium tuberculosis H37Rv in vitro. Doklady Akademii nauk 2010; 434: 5: 705-708. [in Russian]</mixed-citation><mixed-citation xml:lang="en">Андреевская C.H., Смирнова Т.Г., Жогина Ю.А., Смирнова И., Микулович Ю.Л., Сорокоумова Г.М., Черноусова Л.Н., Селищева А.А., Швец В.И. Влияние экзогенного кардиолипина на рост и жизнеспособность Mycobacterium tuberculosis H37Rv in vitro. Доклады Академии наук 2010; 434: 5: 705-708. / Andreevskaja S.N., Smirnova T.G., Zhogina Ju.A., Smirnova T.G., Mikulovich Ju.L., Sorokoumova G.M., Chernousova L.N., Selishheva A.A., Shvec V.I. Vlijanie jekzogennogo kardiolipina na rost i zhiznesposobnost' Mycobacterium tuberculosis H37Rv in vitro. Doklady Akademii nauk 2010; 434: 5: 705-708. [in Russian]</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Sosunov V., Mischenko V., Eruslanov B., Svetoch E., Shakina Y., Stern N.,Majorov K., Sorokoumova G., Selisheva A., Apt A. Activity of bacteriocins and their complexes with liposomes. J Antimicrob Chemother 2007; 59: 5: 919-925.</mixed-citation><mixed-citation xml:lang="en">Sosunov V., Mischenko V., Eruslanov B., Svetoch E., Shakina Y., Stern N.,Majorov K., Sorokoumova G., Selisheva A., Apt A. Activity of bacteriocins and their complexes with liposomes. J Antimicrob Chemother 2007; 59: 5: 919-925.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Иванов М.А., Карпенко И.Л., Черноусова Л. H., Андреевская C.H., Смирнова Т.Г., Александрова Л.А. Синтез и биологические свойства 5'-арилфосфонатов а-тимидинаБиоорган. Химия 2013; 39: 6: 718- 727. Ivanov M.A., Karpenko I.L., Chernousova L. N., Andreevskaja S.N., Smirnova T.G., Aleksandrova L.A. Sintez i biologicheskie svojstva 5'-arilfosfonatov а-timidinaBioorgan. Himija 2013; 39: 6: 718-727. [in Russian]</mixed-citation><mixed-citation xml:lang="en">Иванов М.А., Карпенко И.Л., Черноусова Л. H., Андреевская C.H., Смирнова Т.Г., Александрова Л.А. Синтез и биологические свойства 5'-арилфосфонатов а-тимидинаБиоорган. Химия 2013; 39: 6: 718- 727. Ivanov M.A., Karpenko I.L., Chernousova L. N., Andreevskaja S.N., Smirnova T.G., Aleksandrova L.A. Sintez i biologicheskie svojstva 5'-arilfosfonatov а-timidinaBioorgan. Himija 2013; 39: 6: 718-727. [in Russian]</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Шмаленюк Э.Р., Карпенко И.Л., Черноусова Л.Н., Чижов А.О., Смирнова Т.Г., Андреевская С.Н., Александрова Л.А. Новые 5-модифицированные производные 2'-дезоксиуридина: синтез и противотуберкулезная активность. Известия Академии наук. Серия химическая. 2014; 5: 1197-1200</mixed-citation><mixed-citation xml:lang="en">Шмаленюк Э.Р., Карпенко И.Л., Черноусова Л.Н., Чижов А.О., Смирнова Т.Г., Андреевская С.Н., Александрова Л.А. Новые 5-модифицированные производные 2'-дезоксиуридина: синтез и противотуберкулезная активность. Известия Академии наук. Серия химическая. 2014; 5: 1197-1200</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Бергельсон Л.Д., Дятловицкая Э.В., Молотковский Ю.Г. Препаративная химия липидов. Под ред. Л.Д. Бергельсон, Э.В. Дятловицкая. М.: Наука, 1981; 259. / Bergel'son L.D., Djatlovickaja Je.V., Molotkovskij Ju.G. Preparativnaja himija lipidov. Pod red. L.D. Bergel'son, Je.V. Djatlovickaja. M.: Nauka, 1981; 259. [in Russian]</mixed-citation><mixed-citation xml:lang="en">Бергельсон Л.Д., Дятловицкая Э.В., Молотковский Ю.Г. Препаративная химия липидов. Под ред. Л.Д. Бергельсон, Э.В. Дятловицкая. М.: Наука, 1981; 259. / Bergel'son L.D., Djatlovickaja Je.V., Molotkovskij Ju.G. Preparativnaja himija lipidov. Pod red. L.D. Bergel'son, Je.V. Djatlovickaja. M.: Nauka, 1981; 259. [in Russian]</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Niks M, Otto M. Towards an optimized MTT assay. J Immunol Methods. 1990; 130: 1: 149-151.</mixed-citation><mixed-citation xml:lang="en">Niks M, Otto M. Towards an optimized MTT assay. J Immunol Methods. 1990; 130: 1: 149-151.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Маланичева И.А., Козлов Д.Г., Сумарукова И.Г., Ефременкова О.В., Зенкова В.А., Катруха Г.С., Резникова М.И., Тарасова О.Д., Синеокий С.П., Эль-Регистан Г.И. Антимикробная активность представителей вида Bacillus megaterium. Микробиология 2012; 81: 2: 196-204. / Malanicheva I.A., Kozlov D.G., Sumarukova I.G., Efremenkova O.V., Zenkova V.A., Katruha G.S., Reznikova M.I., Tarasova O.D., Sineokij S.P., Jel'-Registan G.I. Antimikrobnaja aktivnost' predstavitelej vida Bacillus megaterium. Mikrobiologija 2012; 81: 2: 196-204. [in Russian]</mixed-citation><mixed-citation xml:lang="en">Маланичева И.А., Козлов Д.Г., Сумарукова И.Г., Ефременкова О.В., Зенкова В.А., Катруха Г.С., Резникова М.И., Тарасова О.Д., Синеокий С.П., Эль-Регистан Г.И. Антимикробная активность представителей вида Bacillus megaterium. Микробиология 2012; 81: 2: 196-204. / Malanicheva I.A., Kozlov D.G., Sumarukova I.G., Efremenkova O.V., Zenkova V.A., Katruha G.S., Reznikova M.I., Tarasova O.D., Sineokij S.P., Jel'-Registan G.I. Antimikrobnaja aktivnost' predstavitelej vida Bacillus megaterium. Mikrobiologija 2012; 81: 2: 196-204. [in Russian]</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Shmalenyuk E.R., Chernousova L.N., Karpenko I.L., Kochetkov S.N., Smirnova T.G., Andreevskaya S.N., Efremenkova O.V., Alexandrova L.A. Inhibition of Mycobacterium tuberculosis strains H37Rv and MDR MS-115 by a new set of C5 modified pyrimidine nucleosides. Bioorg.Med. Chem. 2013; 21: 4874-4884.</mixed-citation><mixed-citation xml:lang="en">Shmalenyuk E.R., Chernousova L.N., Karpenko I.L., Kochetkov S.N., Smirnova T.G., Andreevskaya S.N., Efremenkova O.V., Alexandrova L.A. Inhibition of Mycobacterium tuberculosis strains H37Rv and MDR MS-115 by a new set of C5 modified pyrimidine nucleosides. Bioorg.Med. Chem. 2013; 21: 4874-4884.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Александрова Л.А., Шмаленюк Э.Р., Кочетков С.H., Ерохин В.В., Смирнова Т.Г., Андреевская С.Н., Черноусова Л.Н. Новые 5 модифицированные пиримидиновые нуклеозиды - ингибиторы роста микобактерий. Acta Naturae 2010; 3: 89-92. / Aleksandrova L.A., Shmalenjuk Je.R., Kochetkov S.N., Erohin V.V., Smirnova T.G. , Andreevskaja S.N., Chernousova L.N. Novye 5 modificirovannye pirimidinovye nukleozidy - ingibitory rosta mikobakterij. Acta Naturae 2010; 3: 89-92. [in Russian].</mixed-citation><mixed-citation xml:lang="en">Александрова Л.А., Шмаленюк Э.Р., Кочетков С.H., Ерохин В.В., Смирнова Т.Г., Андреевская С.Н., Черноусова Л.Н. Новые 5 модифицированные пиримидиновые нуклеозиды - ингибиторы роста микобактерий. Acta Naturae 2010; 3: 89-92. / Aleksandrova L.A., Shmalenjuk Je.R., Kochetkov S.N., Erohin V.V., Smirnova T.G. , Andreevskaja S.N., Chernousova L.N. Novye 5 modificirovannye pirimidinovye nukleozidy - ingibitory rosta mikobakterij. Acta Naturae 2010; 3: 89-92. [in Russian].</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Matyugina E., Khandazhinskaya A., Chernousova, L., Andreevskaya S., Smirnova T., Chizhov A., Karpenko I., Kochetkov S., Alexandrova L.The synthesis and antituberculosis activity of 5'-nor carbocyclic uracil derivatives. Bioorg Med Chem 2012; 20: 6680-6686.</mixed-citation><mixed-citation xml:lang="en">Matyugina E., Khandazhinskaya A., Chernousova, L., Andreevskaya S., Smirnova T., Chizhov A., Karpenko I., Kochetkov S., Alexandrova L.The synthesis and antituberculosis activity of 5'-nor carbocyclic uracil derivatives. Bioorg Med Chem 2012; 20: 6680-6686.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Александрова Л.А., Ефременкова О.В., Андронова В.Л., Галегов Г.А., Сольев П.Н., Карпенко И.Л., Кочетков С.Н. (4-алкил-1,2,3-триазол-1-ил)метильные производные 2'-дезоксиуридина - ингибиторы роста бактерий и вирусов. Биоорган. Химия 2016; 42: 6: 746-754. / Aleksandrova L.A., Efremenkova O.V., Andronova V.L., Galegov G.A., Sol'ev P.N., Karpenko I.L., Kochetkov S.N. (4-alkil-1,2,3-triazol-1-il)metil'nye proizvodnye 2'-dezoksiuridina - ingibitory rosta bakterij i virusov. Bioorgan. Himija 2016; 42: 6: 746-754. [in Russian]</mixed-citation><mixed-citation xml:lang="en">Александрова Л.А., Ефременкова О.В., Андронова В.Л., Галегов Г.А., Сольев П.Н., Карпенко И.Л., Кочетков С.Н. (4-алкил-1,2,3-триазол-1-ил)метильные производные 2'-дезоксиуридина - ингибиторы роста бактерий и вирусов. Биоорган. Химия 2016; 42: 6: 746-754. / Aleksandrova L.A., Efremenkova O.V., Andronova V.L., Galegov G.A., Sol'ev P.N., Karpenko I.L., Kochetkov S.N. (4-alkil-1,2,3-triazol-1-il)metil'nye proizvodnye 2'-dezoksiuridina - ingibitory rosta bakterij i virusov. Bioorgan. Himija 2016; 42: 6: 746-754. [in Russian]</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Rai D., Johar M, Manning T., Agraval B., Kunimoto D.Y., Kumar R. Design and studies of novel 5-substituted alkylpyrimidene nucleosides as potent inhibitors of mycobacteria. J med Chem. 2005; 48: 22: 7012-1017.</mixed-citation><mixed-citation xml:lang="en">Rai D., Johar M, Manning T., Agraval B., Kunimoto D.Y., Kumar R. Design and studies of novel 5-substituted alkylpyrimidene nucleosides as potent inhibitors of mycobacteria. J med Chem. 2005; 48: 22: 7012-1017.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
